Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Manuka Inc (EM) MNKA

Consumer Defensive Healthcare Household & Personal Products Biotechnology
Manuka, Inc., a beauty company, engages in the development and distribution of skincare products in Israel. The company offers face serum with manuka honey and bee venom, face serum with vitamin C, day cream, nourishing night cream with manuka honey and nee venom, eye cream with manuka honey and bee venom, and face cleanser gel. It also distributes manuka honey imported from New Zealand. The... see more

Current News (EXPM:MNKA)

Manuka Announces Review of Strategic Alternatives

GlobeNewswire November 16, 2023

Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria

PR Newswire June 19, 2018

Data Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

PR Newswire June 12, 2018

New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

PR Newswire June 7, 2018

Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections

PR Newswire April 16, 2018

OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

PR Newswire March 8, 2018

Artemis Therapeutics to Present at the 10th Annual LD Micro Main Event

ACCESS Newswire November 29, 2017

Artemis Therapeutics Announces Issuance Of European Patent For Artemisone For The Treatment Of Viral Infections

PR Newswire November 28, 2017

Artemis Therapeutics Receives Orphan Drug Designation From U.S. Food And Drug Administration For Artemisone For The Treatment Of Malaria

PR Newswire November 6, 2017
View More News ››

Opinion & Analysis (EXPM:MNKA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:MNKA)

Be the first to post on this bullboard.

Freegold Ventures Limited

Freegold Ventures Limited

Freegold Ventures Limited is a Canada-based company focused on exploration in Alaska. The Company holds the Summit Gold ...
View More »

Podcasts